On Sunday night Purdue Pharma L.P. filed Chapter 11 seeking protection from more than 2,600 state and federal lawsuits.  Purdue Pharma L.P. is the maker of OxyContin, the drug widely seen as igniting the opioid crisis.  This after the company proposed settling most of the suits for $10 Billion.  The Chapter 11 filing and proposed settlement is expected to be challenged by many state Attorney Generals.

Green & Sklarz attorneys routinely represent business clients in complex bankruptcy cases in jurisdictions outside of Connecticut, including the Southern District of New York. Green & Sklarz is aptly able to assist clients involved in the Purdue Pharma case at rates that are highly competitive relative to New York based law firms. Green & Sklarz can also serve as local counsel in the Purdue Pharma case for those firms outside of the district that require a local firm well versed in the practice and procedures of the Southern District of New York bankruptcy courts.